Loyer EM - Search Results

1

Phase II clinical trial of interleukin-12 in patients with relapsed and refractory non-Hodgkin's lymphoma and Hodgkin's disease.

Younes A, Pro B, Robertson MJ, Flinn IW, Romaguera JE, Hagemeister F, Dang NH, Fiumara P, Loyer EM, Cabanillas FF, McLaughlin PW, Rodriguez MA, Samaniego F. Younes A, et al. Among authors: loyer em. Clin Cancer Res. 2004 Aug 15;10(16):5432-8. doi: 10.1158/1078-0432.CCR-04-0540. Clin Cancer Res. 2004. PMID: 15328181 Clinical Trial.

2

Phase II study of yttrium-90-ibritumomab tiuxetan in patients with relapsed or refractory mantle cell lymphoma.

Wang M, Oki Y, Pro B, Romaguera JE, Rodriguez MA, Samaniego F, McLaughlin P, Hagemeister F, Neelapu S, Copeland A, Samuels BI, Loyer EM, Ji Y, Younes A. Wang M, et al. Among authors: loyer em. J Clin Oncol. 2009 Nov 1;27(31):5213-8. doi: 10.1200/JCO.2009.21.8545. Epub 2009 Sep 21. J Clin Oncol. 2009. PMID: 19770379 Clinical Trial.

3

A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix.

Kudelka AP, Levy T, Verschraegen CF, Edwards CL, Piamsomboon S, Termrungruanglert W, Freedman RS, Kaplan AL, Kieback DG, Meyers CA, Jaeckle KA, Loyer E, Steger M, Mante R, Mavligit G, Killian A, Tang RA, Gutterman JU, Kavanagh JJ. Kudelka AP, et al. Clin Cancer Res. 1997 Sep;3(9):1501-5. Clin Cancer Res. 1997. PMID: 9815836 Clinical Trial.

4

Phase II study of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix.

Verschraegen CF, Kavanagh JJ, Loyer E, Bodurka-Bevers D, Kudelka AP, Hu W, Vincent M, Nelson T, Levenback C; Community Clinical Oncology Program. Verschraegen CF, et al. Cancer. 2001 Nov 1;92(9):2327-33. doi: 10.1002/1097-0142(20011101)92:9<2327::aid-cncr1579>3.0.co;2-6. Cancer. 2001. PMID: 11745287 Clinical Trial.

5

Activity of paclitaxel in advanced or recurrent squamous cell cancer of the cervix.

Kudelka AP, Winn R, Edwards CL, Downey G, Greenberg H, Dakhil SR, Freedman RS, Loyer E, Rusinkiewicz J, Gacrama P, Fueger R, Kavanagh JJ. Kudelka AP, et al. Clin Cancer Res. 1996 Aug;2(8):1285-8. Clin Cancer Res. 1996. PMID: 9816298 Clinical Trial.

6

Is resection of colorectal liver metastases after a second-line chemotherapy regimen justified?

Brouquet A, Overman MJ, Kopetz S, Maru DM, Loyer EM, Andreou A, Cooper A, Curley SA, Garrett CR, Abdalla EK, Vauthey JN. Brouquet A, et al. Among authors: loyer em. Cancer. 2011 Oct 1;117(19):4484-92. doi: 10.1002/cncr.26036. Epub 2011 Mar 28. Cancer. 2011. PMID: 21446046 Free PMC article.

7

A phase II clinical and pharmacological study of oral 9-nitrocamptothecin in patients with refractory epithelial ovarian, tubal or peritoneal cancer.

Verschraegen CF, Gupta E, Loyer E, Kavanagh JJ, Kudelka AP, Freedman RS, Edwards CL, Harris N, Steger M, Steltz V, Giovanella BC, Stehlin JS. Verschraegen CF, et al. Anticancer Drugs. 1999 Apr;10(4):375-83. doi: 10.1097/00001813-199904000-00005. Anticancer Drugs. 1999. PMID: 10378672 Clinical Trial.

8

An update of a phase II study of paclitaxel in advanced or recurrent squamous cell cancer of the cervix.

Kudelka AP, Winn R, Edwards CL, Downey G, Greenberg H, Dakhil SR, Freedman RS, LoCoco S, Umbreit J, Delmore JE, Arbuck S, Loyer E, Gacrama P, Fueger R, Kavanagh JJ. Kudelka AP, et al. Anticancer Drugs. 1997 Aug;8(7):657-61. doi: 10.1097/00001813-199708000-00002. Anticancer Drugs. 1997. PMID: 9311440 Clinical Trial.

9

A phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for 5 days every 3 weeks to patients with advanced ovarian, tubal or peritoneal cancer resistant to platinum, taxane and topotecan.

Verschraegen CF, Kudelka AP, Hu W, Vincent M, Kavanagh JJ, Loyer E, Bastien L, Duggal A, De Jager R. Verschraegen CF, et al. Cancer Chemother Pharmacol. 2004 Jan;53(1):1-7. doi: 10.1007/s00280-003-0696-7. Epub 2003 Oct 28. Cancer Chemother Pharmacol. 2004. PMID: 14586557 Clinical Trial.

10

Clinical evaluation of the delivery and safety of aerosolized liposomal 9-nitro-20(s)-camptothecin in patients with advanced pulmonary malignancies.

Verschraegen CF, Gilbert BE, Loyer E, Huaringa A, Walsh G, Newman RA, Knight V. Verschraegen CF, et al. Clin Cancer Res. 2004 Apr 1;10(7):2319-26. doi: 10.1158/1078-0432.ccr-0929-3. Clin Cancer Res. 2004. PMID: 15073107 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

88 results

Search Page